Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human papillomavirus (HPV) E7 protein is a viral oncoprotein expressed by high-risk HPV types. It disrupts normal cellular processes, promoting uncontrolled cell proliferation and genomic instability, and is critical for the development of HPV-associated cancers. E7 primarily functions by binding to and degrading the retinoblastoma tumor suppressor protein (pRb), releasing E2F transcription factors and driving cells into S-phase. It also inhibits apoptosis, modulates immune responses, and collaborates with the HPV E6 oncoprotein to transform host epithelial cells.
Inhibition of E7 protein function, such as E7-pRb interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human papillomavirus E7 protein (E7).